Chuck Padala | Managing Director, LifeSci Advisors |
Adi Mohanty | Chief Executive Officer |
Eric d’Esparbes | Chief Financial Officer |
Julian Harrison | BTIG |
Sahil Kazmi | B. Riley Securities |
Welcome to the Biora Therapeutics First Quarter 2022 Earnings Call.
During the presentation, all participants will be in a listen-only mode. Afterwards, we’ll conduct a question-and-answer session. [Operator Instructions] As a reminder, today’s conference is being recorded. I’ll now turn the call over to Chuck Padala, Managing Director with LifeSci Advisors, Biora Therapeutics Investor Relations firm.